Literature DB >> 24368856

Malignant pleural effusion.

A M Egan1, D McPhillips, S Sarkar, D P Breen.   

Abstract

Malignant pleural effusion (MPE) refers to the presence of neoplastic cells in the pleural fluid. Approximately 40 000 people per year in the UK are affected by MPE and it is associated with significant morbidity and an overall poor prognosis. Management should be prompt and care plans should be individualized and involve a multidisciplinary team of healthcare professionals. This article reviews the pathophysiology of MPE along with available investigations and management strategies for these patients.

Entities:  

Mesh：

Year:  2013        PMID： 24368856     DOI： 10.1093/qjmed/hct245

Source DB:  PubMed          Journal:  QJM        ISSN： 1460-2393


  11 in total

Review 1.  Pleural involvement in lung cancer.

Authors:  Theodora Agalioti; Anastasios D Giannou; Georgios T Stathopoulos
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

2.  Sarcopenia in patients with malignant pleural effusion: impact on symptoms, health status, and response to hospitalization.

Authors:  Janet Rodríguez-Torres; Laura López-López; Irene Cabrera-Martos; Gerald Valenza-Demet; Lawrence P Cahalin; Marie Carmen Valenza
Journal:  Support Care Cancer       Date:  2019-04-03       Impact factor: 3.603

Review 3.  Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases.

Authors:  D Marquez-Medina; S Popat
Journal:  Clin Transl Oncol       Date:  2015-12-17       Impact factor: 3.405

4.  Homocysteine: new tumor marker in pleural fluid.

Authors:  Jose D Santotoribio; Consuelo Cañavate-Solano; Angela Garcia-de la Torre; Luis Del Valle-Vazquez; Francisco Arce-Matute; Juan F Cuadros-Muñoz; Maria J Sanchez del Pino; Manuel J Bandez-Ruiz; Carmen Piñuela-Rojas; Santiago Perez-Ramos
Journal:  Tumour Biol       Date:  2015-05-09

5.  Diagnostic value of CD206+CD14+ macrophages in diagnosis of lung cancer originated malignant pleural effusion.

Authors:  Xue-Bin Pei; Xiu-Zhi Wu; Feng-Shuang Yi; Kan Zhai; Huan-Zhong Shi
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

6.  Malignant Pleural Effusion from Metastatic Prostate Cancer: A Case Report with Unusual Cytologic Findings.

Authors:  Jinyoung Jeon; Tae-Jung Kim; Hong Sik Park; Kyo-Young Lee
Journal:  J Pathol Transl Med       Date:  2018-06-07

7.  Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.

Authors:  Chang Youl Lee; Ji Young Hong; Myung Goo Lee; In Bum Suh
Journal:  Yonsei Med J       Date:  2017-11       Impact factor: 2.759

8.  Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer.

Authors:  Rong Biaoxue; Li Min; Fu Tian; Gao Wenlong; Liu Hua
Journal:  BMC Pulm Med       Date:  2018-12-06       Impact factor: 3.317

9.  The diagnostic value of pleural fluid homocysteine in malignant pleural effusion.

Authors:  Jose D Santotoribio; Luis Del Valle-Vazquez; Angela García-de la Torre; Daniel Del Castillo-Otero; Juan-Bosco Lopez-Saez; Maria J Sanchez Del Pino
Journal:  PLoS One       Date:  2019-09-24       Impact factor: 3.240

10.  Diagnostic accuracy of the cancer ratio for the prediction of malignant pleural effusion: evidence from a validation study and meta-analysis.

Authors:  Ying Zhang; Xiaoou Li; Junhui Liu; Xueru Hu; Chun Wan; Rui Zhang; Yongchun Shen
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.